Lung cancer testing and treatment outcomes research study platform
Part of Cancer, Lungs & breathing clinical trials.
This study collects information from adults with different types and stages of lung cancer to connect molecular test results with treatment choices and outcomes. It may help improve how lung cancer is diagnosed and managed by building a better understanding of what works for different patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years old or older
- You have a confirmed diagnosis of lung cancer (NSCLC or SCLC)
- You can sign consent and complete questionnaires about how you feel
- You can enroll within 4 weeks of starting your first cancer treatment, or within 4 weeks of diagnosis if you’re only getting comfort care
- Your cancer stage matches what the study is enrolling (for example, stage IIIB/C or IV for advanced NSCLC, or earlier stages for some NSCLC patients)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lung cancer over time to see how the disease changes, especially during and after treatment. By collecting tumor samples and blood tests every few months, researchers hope to understand why some cancers come back or become resistant, and find better ways to treat them.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This study collects blood and tissue samples from people with non-small cell lung cancer (NSCLC) either before or after treatment. It aims to help researchers learn more about how tumors respond, especially in cancers with specific genetic changes or after certain pre-surgery therapies.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This study is looking at how non-small cell lung cancer (NSCLC) changes and progresses over time, from early to advanced stages. By studying people with all stages of the disease, researchers hope to learn more about what affects a person's prognosis and how the cancer evolves. This may help doctors better understand the cancer and develop better treatments.
This study looks at how different treatments work for people with advanced lung cancer that has a MET mutation. It aims to understand real-world treatment patterns and outcomes to help guide future care.
Hear when a new Non Small Cell Lung Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.